In 2022, it is anticipated that the global Central Lab Market will be worth roughly US$2.42 billion. Considering the increasing growth of clinical trials around the world, it is predicted that the market will expand overall between 2022 and 2032 at a healthy CAGR of around 6%, topping US$ 4.0 billion by the end of that …